Hydroxychloroquine, azithromycin and methylprednisolone and in hospital survival in severe COVID-19 pneumonia

Introduction: Severe COVID-19 pneumonia has two phases that are not mutually exclusive. Repurposed drugs target only one phase and the association of combination therapy to survival is unknown. Objective: To determine the association of hydroxychloroquine, azithromycin, and methylprednisolone versus...

Descripción completa

Detalles Bibliográficos
Autores principales: Go, Ronaldo C., Nyirenda, Themba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551186/
https://www.ncbi.nlm.nih.gov/pubmed/36238570
http://dx.doi.org/10.3389/fphar.2022.935370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551186/
https://www.ncbi.nlm.nih.gov/pubmed/36238570
http://dx.doi.org/10.3389/fphar.2022.935370

Ejemplares similares